Body Composition, Adherence to Anthracycline and Taxane-Based Chemotherapy, and Survival After Nonmetastatic Breast Cancer-Reference-Cited by-同舟云学术

Body Composition, Adherence to Anthracycline and Taxane-Based Chemotherapy, and Survival After Nonmetastatic Breast Cancer

Published:2020-02-01 Issue:2 Volume:6 Page:264
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Cespedes Feliciano Elizabeth M.¹,Chen Wendy Y.²³,Lee Valerie¹,Albers Kathleen B.¹,Prado Carla M.⁴,Alexeeff Stacey¹,Xiao Jingjie⁵,Shachar Shlomit S.⁶⁷,Caan Bette J.¹

Affiliation:

1. Division of Research, Kaiser Permanente Northern California, Oakland

2. Channing Division of Network Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts

3. Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts

4. Department of Agricultural, Food and Nutritional Science, University of Alberta, 2-06 Agriculture/Forestry Centre, Edmonton, Alberta, Canada

5. Covenant Health Palliative Institute, Grey Nuns Community Hospital, St. Marguerite Health Services Centre, Edmonton, Alberta, Canada

6. Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill

7. Division of Oncology, Rambam Health Care Campus, Haifa, Israel

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2757079/jamaoncology_cespedes_feliciano_2019_oi_190091.pdf

Reference36 articles.

1. Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: the Cancer and Leukemia Group B Experience.;Muss;J Clin Oncol,2007

2. Body composition in chemotherapy: the promising role of CT scans.;Prado;Curr Opin Clin Nutr Metab Care,2013

3. The emerging role of computerized tomography in assessing cancer cachexia.;Prado;Curr Opin Support Palliat Care,2009

4. Body fat composition impacts the hematologic toxicities and pharmacokinetics of doxorubicin in Asian breast cancer patients.;Wong;Breast Cancer Res Treat,2014

5. An exploratory study of body composition as a determinant of epirubicin pharmacokinetics and toxicity.;Prado;Cancer Chemother Pharmacol,2011

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adipocyte maturation impacts daunorubicin disposition and metabolism;European Journal of Clinical Investigation;2024-09-10

2. Scalp Cooling in Preventing Chemotherapy-Induced Alopecia for Early Breast Cancer Patients: Long-Term Outcomes of Real- Life Data;2024-09-03

3. Combined Chemo- and Photothermal Therapies of Non-Small Cell Lung Cancer Using Polydopamine/Au Hollow Nanospheres Loaded with Doxorubicin;International Journal of Nanomedicine;2024-09

4. An interactive dose optimizer based on population pharmacokinetic study to guide dosing of methotrexate in Chinese patients with osteosarcoma;Cancer Chemotherapy and Pharmacology;2024-08-24

5. Body composition and metabolic profile during chemotherapy in early-stage breast and cervical cancer patients in Douala, Cameroon: A hospital-based study;2024-07-12